These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6203936)

  • 1. The neuroleptic syndrome and central dopamine metabolites.
    Tollefson GD; Garvey MJ
    J Clin Psychopharmacol; 1984 Jun; 4(3):150-3. PubMed ID: 6203936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypokinetic-rigid extrapyramidal side effects of neuroleptics: the relationship of the silent period in EMG and HVA and 5-HIAA in CSF.
    Yazici O; Hizal A; Eroğlu L; Baslo A; Yazici J
    J Neurol Neurosurg Psychiatry; 1986 Apr; 49(4):448-50. PubMed ID: 2422327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
    Cramer H; Warter JM; Renaud B
    Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
    [No Abstract]   [Full Text] [Related]  

  • 4. Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment.
    Bagdy G; Perényi A; Frecska E; Révai K; Papp Z; Fekete MI; Arató M
    Psychopharmacology (Berl); 1985; 85(1):62-4. PubMed ID: 2580329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late chronic dyskinesia from neuroleptic drugs (CSF and pharmacological data) (author's transl)].
    Roccatagliata G; Albano C; Besio G
    Riv Patol Nerv Ment; 1978 Sep; 98(4):228-32. PubMed ID: 33440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Homovanillic acid content in the cerebrospinal fluid as an index of dopamine cerebral metabolism before and after a stereotaxic operation in patients with extrapyramidal hyperkinetic syndromes].
    Barkhatova VP; Kandel' EI; Omorova TM; Demina EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):1050-5. PubMed ID: 6382885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of clozapine response in schizophrenia.
    Pickar D; Owen RR; Litman RE; Hsiao JK; Su TP
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():129-32. PubMed ID: 7525541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid monoamine metabolism in a case of neuroleptic malignant syndrome improved by electroconvulsive therapy.
    Nisijima K; Oyafuso K; Shimada T; Hosino H; Ishiguro T
    Biol Psychiatry; 1996 Mar; 39(5):383-4. PubMed ID: 8704073
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
    Eklundh T; Eriksson M; Sjöberg S; Nordin C
    J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
    Poceta JS; Parsons L; Engelland S; Kripke DF
    Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The monamine metabolites in the CSF of the patients with spinocerebellar degeneration and motor neuron disease (author's transl)].
    Yamamoto M
    Rinsho Shinkeigaku; 1980 Jul; 20(7):503-9. PubMed ID: 6161732
    [No Abstract]   [Full Text] [Related]  

  • 12. Liquid chromatographic monitoring of CSF metabolites.
    Wightman RM; Plotsky PM; Strope E; Delcore R; Adams RN
    Brain Res; 1977 Aug; 131(2):345-9. PubMed ID: 890461
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF dopamine turnover and positive schizophrenic symptoms after withdrawal of long-term neuroleptic treatment.
    Frecska E; Perényi A; Bagdy G; Révai K
    Psychiatry Res; 1985 Nov; 16(3):221-6. PubMed ID: 2868474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemical mechanisms of extrapyramidal-motoric effect of haloperidol in man].
    Eben E; Ackenheil M; Raese J; Rüther E
    Arzneimittelforschung; 1974 Aug; 24(8):1133-5. PubMed ID: 4479374
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
    Pranzatelli MR; Huang Y; Tate E; Stanley M; Noetzel MJ; Gospe SM; Banasiak K
    Ann Neurol; 1995 Feb; 37(2):189-97. PubMed ID: 7531417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic and dopaminergic metabolites in cerebrospinal fluid of epileptics.
    Mohan A; Nag D; Misra RN; Gujrati VR; Shanker K; Doval DC; Saxena RC; Bhargava KP
    Pharmazie; 1982 Nov; 37(11):803. PubMed ID: 6187028
    [No Abstract]   [Full Text] [Related]  

  • 18. Free and conjugated amines in human lumbar cerebrospinal fluid.
    Tyce GM; Rorie DK; Byer DE; Danielson DR
    J Neurochem; 1985 Jan; 44(1):322-4. PubMed ID: 2578061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of cerebral ischemia on the level of metabolites of dopamine and serotonin in the rat cerebrospinal fluid].
    Ceballos I; Laude D; Capdeville C; Elghozi JL
    J Pharmacol; 1984; 15(3):319-30. PubMed ID: 6208429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of homovanillic acid determination in ventricular cerebrospinal fluid to assess brain dopamine metabolism in several extrapyramidal diseases].
    Barkhatova VP; Larskiĭ EG
    Lab Delo; 1979; (2):79-83. PubMed ID: 85750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.